Skip to main content
. 2021 Mar 13;9(3):297. doi: 10.3390/biomedicines9030297

Figure 7.

Figure 7

The molecular regulatory mechanism underlying UA’s anticancer activity in NSCLC cells, and UA’s inhibition of the EGFR/JAK2/STAT3 signaling pathway and PD-L1. Continuous black point arrow denotes the activity of UA, dotted point arrows denotes blockage of signals, and red block arrow denotes the inhibition of EGFR signaling by UA.